D-C Zhou

431 total citations
11 papers, 284 citations indexed

About

D-C Zhou is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, D-C Zhou has authored 11 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in D-C Zhou's work include Drug Transport and Resistance Mechanisms (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Acute Myeloid Leukemia Research (4 papers). D-C Zhou is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Acute Myeloid Leukemia Research (4 papers). D-C Zhou collaborates with scholars based in France, Italy and United States. D-C Zhou's co-authors include R Zittoun, J. P. Marie, Sandeep Gurbuxani, Ollivier Legrand, Ghislaine Simonin, Sylvie Ramond, J.Y. Perrot, Bernard Rio, Alain Delmer and Florence Cymbalista and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

D-C Zhou

11 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D-C Zhou France 10 187 155 99 53 39 11 284
Da-Cheng Zhou France 7 141 0.8× 235 1.5× 166 1.7× 46 0.9× 20 0.5× 10 327
K. De Leeuw Netherlands 6 252 1.3× 147 0.9× 156 1.6× 42 0.8× 74 1.9× 8 364
J.L. Merlin France 9 179 1.0× 149 1.0× 63 0.6× 33 0.6× 25 0.6× 22 299
Julie Turzanski United Kingdom 11 173 0.9× 145 0.9× 119 1.2× 39 0.7× 34 0.9× 15 342
J. Wallner Austria 5 334 1.8× 198 1.3× 113 1.1× 51 1.0× 64 1.6× 7 403
PJ Burke United States 6 106 0.6× 221 1.4× 191 1.9× 32 0.6× 16 0.4× 9 489
Susan Wittig Germany 13 120 0.6× 235 1.5× 58 0.6× 34 0.6× 22 0.6× 25 387
Y Uzuka Japan 9 130 0.7× 141 0.9× 104 1.1× 54 1.0× 4 0.1× 37 320
Rebeca Rodríguez‐Veiga Spain 10 117 0.6× 147 0.9× 171 1.7× 45 0.8× 17 0.4× 39 326
Albert Kheradpour United States 8 60 0.3× 95 0.6× 73 0.7× 89 1.7× 22 0.6× 18 247

Countries citing papers authored by D-C Zhou

Since Specialization
Citations

This map shows the geographic impact of D-C Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D-C Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D-C Zhou more than expected).

Fields of papers citing papers by D-C Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D-C Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D-C Zhou. The network helps show where D-C Zhou may publish in the future.

Co-authorship network of co-authors of D-C Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of D-C Zhou. A scholar is included among the top collaborators of D-C Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D-C Zhou. D-C Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gallagher, Robert E., D-C Zhou, Wei Ding, et al.. (2006). Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure. Leukemia. 20(4). 556–562. 19 indexed citations
3.
Gurbuxani, Sandeep, D-C Zhou, Ghislaine Simonin, et al.. (1998). Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India. Annals of Hematology. 76(5). 195–200. 12 indexed citations
4.
Hunault, Mathilde, D-C Zhou, Alain Delmer, et al.. (1997). Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment. Annals of Hematology. 74(2). 65–71. 48 indexed citations
5.
Zhou, D-C, Ghislaine Simonin, A‐M Faussat, R Zittoun, & J. P. Marie. (1997). Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells. Leukemia. 11(9). 1516–1522. 17 indexed citations
6.
Marie, J. P., D-C Zhou, Sandeep Gurbuxani, Ollivier Legrand, & R Zittoun. (1996). MDR1/P-glycoprotein in haematological neoplasms. European Journal of Cancer. 32(6). 1034–1038. 61 indexed citations
7.
Russo, Domenico, Angela Michelutti, Daniela Damiani, et al.. (1995). MDR-related P170-glycoprotein modulates cytotoxic activity of homoharringtonine.. PubMed. 9(3). 513–6. 14 indexed citations
8.
Russo, Domenico, J. P. Marie, D-C Zhou, et al.. (1994). Evaluation of the Clinical Relevance of the Anionic Glutathione-S-Transferase (GSTπ) and Multidrug Resistance (mdr-1) Gene Coexpression in Leukemias and Lymphomas. Leukemia & lymphoma. 15(5-6). 453–468. 15 indexed citations
9.
Zhou, D-C, et al.. (1993). Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.. PubMed. 7(6). 825–31. 61 indexed citations
10.
Riou, G, Michel Barrois, & D-C Zhou. (1991). Expression of anionic glutathione S transferase (GSTπ) gene in carcinomas of the uterine cervix and in normal cervices. British Journal of Cancer. 63(2). 191–194. 7 indexed citations
11.
Zhou, D-C, et al.. (1990). Expression of Multidrug-Resistance (MDR1) Gene in Normal Epithelia and in Invasive Carcinomas of the Uterine Cervix. JNCI Journal of the National Cancer Institute. 82(18). 1493–1496. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026